BSX Stock Price, Chart, Stats & News

Boston Scientific Corporation
Save
66.35B
Market cap
14.40x
Current P/E
13.19x
Forward P/E
BSX chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 69.01% |
Operating margin | 19.78% |
Pretax margin | 16.86% |
Net margin | 14.40% |
Effective tax rate | 14.56% |
ROA | 6.62% |
ROE | 12.53% |
D/E | 0.51x |
Interest coverage ratio | 11.22x |
BSX valuation
P/E | 14.40x |
P/S | 5.11x |
P/B | 4.23x |
P/CF | 22.62x |
P/FCF | 28.31x |
P/OCF | 22.62x |
PEG | 9.58x |
EV multiple | 18.80x |
About
Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological and pelvic health concerns.
Similar securities
Based on sector and market capitalization
Report issue











